UTHR

Covered Call Opportunities for February 2010	United Therapeutics Corporation Q4 2009 Earnings Call Transcript	Stocks Rebound After Early Declines
Are Insiders Buying More or Selling More Now?	Momentum Book Update: Time to Take Risk Off the Table	Roberto Mignone's Bridger Management Adds Financials and Exits 'Hedge Fund Favorite' Names
Roberto Mignone's Bridger Management Adds Financials and Exits 'Hedge Fund Favorite' Names	The Fourth of July, And Investing in America	China Biotech in Review: Pharma IPOs Raise $5.4 Billion in 12 Months
Earnings Could Drive These Two Stocks Higher	20 Breakout Stocks Being Targeted by Short Sellers	Life Science Portfolios: Reflecting on a Year of Out-Performance
Option Activity Alert: SLXP, UTHR, XLB, XLE	Wednesday Options Brief: SLXP, UTHR, XLB & XLE	Healthcare Sector: Stronger Than It Looks
United Therapeutics Swings to Profit in Q4	Do Mergers Means Billions for Biotech?	5 Growth Stocks at Reasonable Valuations
Russell 1,000 Stocks With the Lowest PEG Ratios	United Therapeutics for Profits and Pipeline	6 High-Growth Stocks With Improving Operating Cash Flow
Short Squeeze Ideas: 15 Highly Shorted Stocks Being Snapped Up by Mutual Funds	Wall Street Breakfast: Must-Know News	United Therapeutics: Oversold but Fundamentally Sound

Main menu